Collaboration Agreement with AbbVie (Tables)

9 Months Ended

Sep. 30, 2023

Collaboration Agreement with AbbVie

Summarizes the change in deferred revenue

The following table summarizes the change in deferred revenue (in thousands):

	Three Months Ended September 30, 2023		Nine Months Ended September 30, 2023
Balance at the beginning of the period	$	23,373	$	—
Deferral of revenue		—		30,000
Recognition of unearned revenue		(3,565)		(10,192)
Balance at the end of the period	$	19,808	$	19,808